Page last updated: 2024-09-03

soyasaponin bb and Invasiveness, Neoplasm

soyasaponin bb has been researched along with Invasiveness, Neoplasm in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Elwakeel, A; Kalra, RS; Kaul, SC; Omar, A; Putri, J; Wadhwa, R1
Chou, YT; Hsieh, SL; Lee, OK; Sung, PL; Wang, PH; Wen, KC; Wu, CW1
Chang, WW; Hsu, CC; Lin, TW; Lo, WH; Tsai, YC; Wang, PH; Wu, CY1
Chang, WW; Lin, TW; Tsai, YC; Wang, PH; Yu, CY1

Other Studies

4 other study(ies) available for soyasaponin bb and Invasiveness, Neoplasm

ArticleYear
Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells.
    Scientific reports, 2020, 04-14, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Oleanolic Acid; RNA-Binding Proteins; Saponins; Signal Transduction; Transcriptional Activation; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2020
α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.
    Oncotarget, 2017, Apr-25, Volume: 8, Issue:17

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Galactoside alpha-2,3-Sialyltransferase; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Drug Synergism; ErbB Receptors; Female; Humans; Immunohistochemistry; Immunoprecipitation; Kaplan-Meier Estimate; Mice; Mice, Inbred C57BL; Microarray Analysis; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Oleanolic Acid; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Prognosis; Protein Kinase Inhibitors; Saponins; Sialyltransferases; Signal Transduction; Survival Rate

2017
Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.
    Gynecologic oncology, 2005, Volume: 96, Issue:2

    Topics: beta-Galactoside alpha-2,3-Sialyltransferase; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Oleanolic Acid; Saponins; Sialic Acids; Sialyltransferases

2005
Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells.
    Biochemical and biophysical research communications, 2006, Mar-10, Volume: 341, Issue:2

    Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Membrane; Cell Movement; Extracellular Matrix; Flow Cytometry; Glycine max; Glycosylation; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; NIH 3T3 Cells; Oleanolic Acid; Saponins; Sialic Acids

2006